Related Experiment Video
Updated: May 22, 2026
06:34
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Rendering protein-based particles transiently insoluble for therapeutic applications
Jing Xu1, Jin Wang, J Christopher Luft
1Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Journal of the American Chemical Society
|May 10, 2012
Summary
Researchers developed novel protein particles using a special cross-linker. These particles dissolve only in reducing environments, enabling effective RNA delivery for potential drug and gene applications.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Protein nanoparticles offer potential for therapeutic delivery.
- Controlling nanoparticle stability and release is crucial for efficacy.
- Existing methods may leave chemical residues, impacting safety.
Purpose of the Study:
- To fabricate transiently insoluble protein particles using a novel cross-linker.
- To demonstrate controlled dissolution of protein particles under reducing conditions.
- To evaluate the potential of these particles for self-replicating RNA delivery.
Main Methods:
- Fabrication of bovine serum albumin (BSA) particles.
- Cross-linking BSA using a reductively labile disulfide-based cross-linker.
- Assessment of particle integrity in aqueous solution and under reducing environments.
- Demonstration of RNA delivery using the developed protein particles.
Main Results:
- Successfully fabricated protein particles with transient insolubility.
- Particles maintained integrity in solution and dissolved specifically in a reducing environment.
- Cross-linker cleavage left no detectable chemical residue on amino groups.
- Achieved delivery of self-replicating RNA using the PRINT protein particles.
Conclusions:
- Developed a novel method for creating transiently insoluble protein particles.
- The disulfide-based cross-linker provides controlled release without residue.
- These PRINT protein particles show promise for advanced drug and gene delivery applications.
